International
A combination of antibodies could help stop COVID-19 from spreading to close contacts of known COVID-19 cases, according to US research. The antibody combination, known as REGEN-COV, or a placebo were given to people within 96 hours of a household contact receiving a COVID-19 diagnosis. The study found that symptomatic SARS-CoV-2 infection developed in 11 of 753 participants in the REGENCOV group (1.5 per cent) and in 59 of 752 participants in the placebo group (7.8 per cent). Among those who became infected, REGEN-COV reduced the duration of symptomatic disease and the duration of a high viral load.
From:
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Sign In
